Abstract:Shroom Family Member 3 ( encodes an actin-binding protein that impacts kidney development. Genome-wide association studies (GWAS) identified CKD-associated common variants around and knock-out mice develop glomerular abnormalities. We sought to evaluate the impact of genetically predicted expression on kidney traits and the circulating proteome, and validate findings in a mouse model. Genetic instruments for expression in distinct kidney compartments (glomerular n=240, tubulointerstitial n=311) were constructed using single cell sequencing data from NephQTL2. Using two-sample Mendelian randomization, we evaluated the effects of glomerular and tubulointerstitial expression on kidney traits and the concentration of 1,463 plasma proteins in the UK Biobank and CKDGen Consortium. Genetically predicted tubulointerstitial expression colocalized with the genetic signals for eGFR and albuminuria. A 34% reduction in genetically predicted tubulointerstitial expression was associated with a 0.3% increase in cross-sectional eGFR ( = 6.8×10 ), a 1.5% increase in albuminuria ( = 0.01), and a 2.2% reduction in plasma COL18A1 concentration ( = 1.2×10 ). In contrast, genetically predicted glomerular expression showed neither colocalization nor significant Mendelian randomization results. Using immunofluorescence, heterozygous knockout mice had a concordant reduction of Col18a1 in their kidneys, primarily around the tubules. Thus, reduced tubulointerstitial expression, but not glomerular, is associated with increased cross-sectional eGFR, increased uACR, and reduced plasma COL18A1 and knockout leads to reduced kidney Col18a1, agnostically linking and in CKD pathogenesis.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of action of the Shroom Family Member 3 (SHROOM3) gene in chronic kidney disease (CKD). Specifically, researchers use multi - omics analysis, especially the Mendelian Randomization (MR) method, to evaluate the impact of genetically predicted SHROOM3 expression on kidney characteristics and the circulating proteome, and verify these findings in mouse models. ### Research Background - **SHROOM3 gene**: Encodes a cytoskeleton - related protein that affects kidney development. Genome - wide association studies (GWAS) have identified common variants associated with CKD near the SHROOM3 gene. - **Shroom3 knockout mice**: These mice exhibit glomerular abnormalities, indicating that SHROOM3 plays an important role in kidney function. ### Research Objectives - **Evaluate the impact of SHROOM3 expression**: Researchers hope to use genetically predicted methods to evaluate the impact of SHROOM3 expression in different kidney regions (such as glomeruli and tubulointerstitium) on kidney characteristics (such as estimated glomerular filtration rate eGFR and urinary albumin - to - creatinine ratio uACR) and the circulating proteome. - **Verify the results**: Verify the above - mentioned findings in mouse models, especially the relationship between SHROOM3 and COL18A1. ### Main Findings - **Tubulointerstitial SHROOM3 expression**: - A 34% reduction in genetically predicted tubulointerstitial SHROOM3 expression was significantly associated with a 0.3% increase in eGFR, a 1.5% increase in uACR, and a 2.2% decrease in plasma COL18A1 concentration. - There is a co - localization phenomenon with the genetic signals of eGFR and uACR, indicating the existence of shared causal variants. - **Glomerular SHROOM3 expression**: - Genetically predicted glomerular SHROOM3 expression did not show a significant association with eGFR or uACR. - **Proteomic analysis**: - By analyzing 1,463 plasma proteins, it was found that a reduction in SHROOM3 expression was significantly associated with a decrease in COL18A1 concentration. - **Mouse model verification**: - The expression of Col18a1 in the kidneys of Shroom3 heterozygous knockout mice was reduced, especially around the renal tubules, further verifying the link between SHROOM3 and COL18A1. ### Conclusions - **The role of SHROOM3 in the tubulointerstitium**: A reduction in genetically predicted tubulointerstitial SHROOM3 expression is associated with an increase in eGFR and uACR, which may be related to an increase in the pressure of the kidney filtration system. - **The interaction between SHROOM3 and COL18A1**: A reduction in SHROOM3 expression leads to a decrease in COL18A1 levels, which may affect kidney development and function. ### Significance - **Mechanism exploration**: This study reveals the potential role of SHROOM3 in the pathogenesis of CKD, especially in affecting kidney function by influencing COL18A1. - **Future directions**: Further study of the specific molecular mechanisms between SHROOM3 and COL18A1, and how these mechanisms affect the development and progression of kidney diseases.

Spatial Multi-Omics Connect SHROOM3 and COL18A1 in Chronic Kidney Disease

Shroom3-Rock interaction and profibrotic function: Resolving mechanism of an intronic CKD risk allele.

Plasma proteome analysis implicates novel proteins as potential therapeutic targets for chronic kidney disease: A proteome-wide association study

Multi-Omic Analysis Reveals Genetic Determinants and Therapeutic Targets of Chronic Kidney Disease and Kidney Function

Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease

Identification of Genes Associated with Smad3-dependent Renal Injury by RNA-seq-based Transcriptome Analysis

A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation.

Renal Gene and Protein Expression Signatures for Prediction of Kidney Disease Progression

Bioinformatics analysis reveals CCR7 as a potential biomarker for predicting CKD progression

Brown-Norway Chromosome 1 Mitigates the Upregulation of Proinflammatory Pathways in Mtal Cells and Subsequent Age-Related CKD in Dahl SS/JrHsdMcwi Rats.

Multivariate canonical correlation analysis identifies additional genetic variants for chronic kidney disease

Proteomics of CKD progression in the chronic renal insufficiency cohort

Multimodal single cell sequencing of human diabetic kidney disease implicates chromatin accessibility and genetic background in disease progression

An integrated co-expression network analysis reveals novel genetic biomarkers for immune cell infiltration in chronic kidney disease

Association of Genetically Predicted Skipping of COL4A4 Exon 27 with Hematuria and Albuminuria

Systematic mediation and interaction analyses of kidney function genetic loci in a general population study

Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy

Genetic Loci Influencing Kidney Function and Chronic Kidney Disease

Integrated Proteomic and Metabolomic Modules associated with Risk of Kidney Disease Progression

Proteins Associated with Risk of Kidney Function Decline in the General Population

Analysis of the human kidney transcriptome and plasma proteome identifies markers of proximal tubule maladaptation to injury